UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The international neuroblastoma risk groups (INRG): a preliminary report

European Journal of Cancer, 1997-10, Vol.33 (12), p.2113-2116

1997

Volltextzugriff (PDF)

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

Clinical and experimental immunology, 2003-11, Vol.134 (2), p.253-263

2003

Volltextzugriff (PDF)

A rapid and highly selective approach to cell separations using an immunomagnetic colloid

Journal of immunological methods, 1993-08, Vol.164 (1), p.51-60

1993

Volltextzugriff (PDF)

Detection of melanoma seeding during surgical procedures – an RT-PCR based model

European journal of surgical oncology, 2002-12, Vol.28 (8), p.832-837

2002

Volltextzugriff (PDF)

Targeted cytokine delivery to neuroblastoma

Biochemical Society transactions, 2002-08, Vol.30 (4), p.518-520

2002

Volltextzugriff (PDF)

Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastoma

International journal of cancer, 1989-10, Vol.44 (4), p.573-578

1989

Volltextzugriff (PDF)

L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin

European journal of immunology, 1996-10, Vol.26 (10), p.2508-2516

1996

Volltextzugriff (PDF)

Ubiquitous Cell-Surface Glycoprotein on Tumor Cells is Proliferation-Associated Receptor for Transferrin

Proceedings of the National Academy of Sciences - PNAS, 1981-07, Vol.78 (7), p.4515-4519

1981

Volltextzugriff (PDF)

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation

Journal of clinical oncology, 1992-12, Vol.10 (12), p.1889-1896

1992

Volltextzugriff (PDF)

Sub‐lethal effects of exposing the human melanoma cell line Skmel−23 to 532 nm laser light

International journal of cancer, 1997-09, Vol.72 (6), p.1104-1112

1997

Volltextzugriff (PDF)

A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates

Radiotherapy and oncology, 1995-02, Vol.34 (2), p.121-131

1995

Volltextzugriff (PDF)

The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens

Journal of immunotherapy (1997), 2005-05, Vol.28 (3), p.203-211

2005

Volltextzugriff (PDF)

The bi‐specific CD3 × NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

Clinical and experimental immunology, 2003-11, Vol.134 (2), p.253-263

2003

Volltextzugriff (PDF)

The detection of tyrosinase mRNA in peripheral blood samples is unlikely to aid in the management of patients with localised malignant melanoma

British journal of plastic surgery, 2003-09, Vol.56 (6), p.540-545

2003

Volltextzugriff (PDF)

Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies

British journal of cancer, 1998-06, Vol.77 (12), p.2324-2330

1998

Volltextzugriff (PDF)

Meta‐Iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK‐N‐BE(2C)

International journal of cancer, 1991-01, Vol.47 (1), p.105-109

1991

Volltextzugriff (PDF)

Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: Experiences, improvements and observations

British journal of cancer, 1986-11, Vol.54 (5), p.771-778

1986

Volltextzugriff (PDF)

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment

Journal of clinical oncology, 1993-08, Vol.11 (8), p.1466-1477

1993

Volltextzugriff (PDF)

Uses and Limitations of Monoclonal Antibodies (MoAbs) in the Treatment of Malignant Disease: A Review

Journal of the Royal Society of Medicine, 1993-04, Vol.86 (4), p.219-224

1993

Volltextzugriff (PDF)

The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial

Clinical neuropathology, 1995-05, Vol.14 (3), p.169

1995

Volltextzugriff (PDF)

A model to estimate the dose to tumour following intracavity administration of radioimmunoconjugates to patients with malignant gliomas

British journal of radiology, 1997-11, Vol.70 (839), p.1152-1161

1997

Volltextzugriff (PDF)

A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm

Journal of neuro-oncology, 1991-04, Vol.10 (2), p.111-119

1991

Volltextzugriff (PDF)

N-myc gene expression and oncoprotein characterisation in medulloblastoma

British journal of cancer, 1989-06, Vol.59 (6), p.889-894

1989

Volltextzugriff (PDF)

Expression of neural cell adhesion molecule (NCAM) isoforms in neuroblastoma

Journal of clinical pathology, 1991-07, Vol.44 (7), p.580-585

1991

Volltextzugriff (PDF)

Alpha‐smooth‐muscle actin and desmin expressions in human neuroblastoma cell lines

International journal of cancer, 1991-05, Vol.48 (2), p.277-283

1991

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(153)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(212)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(158)
Biological And Medical Sciences
(93)
Life Sciences & Biomedicine
(89)
Science & Technology
(89)
Medical Sciences
(79)
Oncology
(48)
Animals
(47)
Antibodies, Monoclonal
(47)
Child
(39)
Neurology
(39)
Cell Line
(37)
Mice
(36)
Tumors Of The Nervous System. Phacomatoses
(36)
Child, Preschool
(33)
Female
(29)
Male
(28)
Monoclonal Antibodies
(26)
Neuroblastoma - Immunology
(26)
Antibodies, Monoclonal - Immunology
(25)
Antibodies, Monoclonal - Therapeutic Use
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The international neuroblastoma risk groups (INRG): a preliminary report

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

A rapid and highly selective approach to cell separations using an immunomagnetic colloid

Detection of melanoma seeding during surgical procedures – an RT-PCR based model

Targeted cytokine delivery to neuroblastoma

Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastoma

L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin

Ubiquitous Cell-Surface Glycoprotein on Tumor Cells is Proliferation-Associated Receptor for Transferrin

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation

Sub‐lethal effects of exposing the human melanoma cell line Skmel−23 to 532 nm laser light

A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates

The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens

The bi‐specific CD3 × NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

The detection of tyrosinase mRNA in peripheral blood samples is unlikely to aid in the management of patients with localised malignant melanoma

Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies

Meta‐Iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK‐N‐BE(2C)

Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: Experiences, improvements and observations

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment

Uses and Limitations of Monoclonal Antibodies (MoAbs) in the Treatment of Malignant Disease: A Review

The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial

A model to estimate the dose to tumour following intracavity administration of radioimmunoconjugates to patients with malignant gliomas

A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm

N-myc gene expression and oncoprotein characterisation in medulloblastoma

Expression of neural cell adhesion molecule (NCAM) isoforms in neuroblastoma

Alpha‐smooth‐muscle actin and desmin expressions in human neuroblastoma cell lines

Suchergebnisse filtern